Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Unusual Machines Inc. Common Stock (UMAC) Price & Performance

Heron Therapeutics IncTrade
Unusual Machines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Unusual Machines Inc. Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.36 (market cap $70.25M), while Unusual Machines Inc. Common Stock trades at $17.01 (market cap $885.73M). The key difference: Unusual Machines Inc. Common Stock is far larger — about 12.6× Heron Therapeutics Inc's market cap, and Unusual Machines Inc. Common Stock is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 36 Days and Unusual Machines Inc. Common Stock for 0 Days on average.

HRTXUMAC
Market Cap
$70.25M$885.73M
Volume
2,092,2533,688,533
Sector
HealthTechnology
52-Week High
$1.49$34.06
52-Week Low
$0.27$7.76
Typical Hold Time
36 Days0 Days
Enterprise Value
$176.99M$572.51M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.3906, down 6.02% on the day, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $20.20 million on $154.90 million revenue in 2025, with a negative net income margin of -22.52%. Recent Q2 2026 earnings missed expectations, posting a loss of $0.03 per share versus an expected loss of $0.005. Analyst consensus remains strongly positive with 17 buy ratings out of 19 total.

The outlook is mixed; strong analyst support and improving cash flow trends in 2026 suggest potential, but persistent losses and high valuation multiples like EV/EBITDA of 34.03 pose significant risks. Investment opportunity hinges on future profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.

Unusual Machines Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
67% Buy33% Sell
Avg holding period · 36 Days
UMAC
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Unusual Machines Inc. Common Stock

Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.

Read more on UMAC →